Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 4169 (113th)

S.O.S. Act

referredUnited States· United States Congress· EN

Introduced

6 March 2014

Last action

7 March 2014 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. Edwards, Donna F. [D-MD-4], Rep. Bass, Karen [D-CA-37], Rep. Carson, André [D-IN-7], Rep. Cummings, Elijah E. [D-MD-7], Rep. Ellison, Keith [D-MN-5], Rep. Keating, William R. [D-MA-9], Rep. Lee, Barbara [D-CA-12], Rep. Lynch, Stephen F. [D-MA-8], Rep. Michaud, Michael H. [D-ME-2], Rep. Rangel, Charles B. [D-NY-15], Rep. Ryan, Tim [D-OH-13], Rep. Schwartz, Allyson Y. [D-PA-13], Rep. Serrano, Jose E. [D-NY-15], Rep. Shea-Porter, Carol [D-NH-1], Rep. Tierney, John F. [D-MA-6], Rep. Tonko, Paul [D-NY-20], Rep. Wilson, Frederica S. [D-FL-24], Rep. Foster, Bill [D-IL-11], Sen. Luján, Ben Ray [D-NM], Sen. Welch, Peter [D-VT], Rep. O'Rourke, Beto [D-TX-16], Rep. Moran, James P. [D-VA-8], Rep. Moore, Gwen [D-WI-4], Rep. Conyers, John, Jr. [D-MI-13], Rep. Rush, Bobby L. [D-IL-1], Rep. Lewis, John [D-GA-5], Rep. McGovern, James P. [D-MA-2], Rep. Roybal-Allard, Lucille [D-CA-40], Rep. Ruiz, Raul [D-CA-25], Rep. Kuster, Ann M. [D-NH-2], Rep. Beatty, Joyce [D-OH-3], Rep. Clark, Katherine M. [D-MA-5], Rep. Carney, John C., Jr. [D-DE-At Large], Rep. Lowey, Nita M. [D-NY-17], Rep. Loebsack, David [D-IA-2], Rep. Maloney, Sean Patrick [D-NY-18], Rep. Blumenauer, Earl [D-OR-3], Rep. Cartwright, Matt [D-PA-17], Rep. Pingree, Chellie [D-ME-1], Rep. Capuano, Michael E. [D-MA-8]

Subjects

Healthcare

Source updated

12 August 2025

Healthcare

Official sourceDownload fileView documentsShare

Summary

Stop Overdose Stat Act or the S.O.S. Act - Requires the Secretary of Health and Human Services (HHS), acting through the Director of the Centers for Disease Control and Prevention (CDC), to: (1) award grants or enter into cooperative agreements to enable eligible entities to reduce deaths occurring from drug overdoses, and (2) give priority to eligible public health agencies or community-based organizations that have expertise in preventing deaths occurring from overdoses in high risk populations. Conditions receipt of a grant or agreement on an entity agreeing to: (1) use it for purchasing and distributing the drug naloxone, (2) report to the Secretary and the coordinating center (established under this Act) on the results of the activities supported, and (3) make available non-federal contributions of at least 50% of the federal funds provided. Requires a recipient to use such grant or agreement for: (1) educating prescribers and pharmacists about overdose prevention and naloxone prescription; (2) training first responders, other individuals in a position to respond to an overdose, and law enforcement and corrections officials on the effective response to individuals who have overdosed on drugs; (3) implementing and enhancing programs to provide overdose prevention, recognition, treatment, and response; and/or (4) expanding such activities. Requires the Director to establish and provide for the operation of a coordinating center responsible for: (1) collecting, compiling, disseminating, and evaluating data on such activities; (2) developing best practices for preventing deaths occurring from drug overdoses; and (3) making such best practices specific to the type of community involved. Requires the Director to award grants or cooperative agreements to improve drug overdose surveillance and reporting capabilities. Amends the Public Health Service Act to require the Secretary to develop and submit to Congress a plan to reduce the number of deaths occurring from overdoses, to include implementation of a campaign to educate prescribers and the public about overdose prevention and naloxone prescription. Requires the Director of the National Institute on Drug Abuse to: (1) prioritize and conduct or support research on drug overdose and overdose prevention, and (2) support research on the development of formulations of naloxone and dosage delivery devices specifically intended to be used for the prehospital treatment of unintentional drug overdose.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 6 March 2014

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 6 March 2014

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 6 March 2014

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 7 March 2014

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 6 March 2014

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 6 March 2014

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 6 March 2014

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.